CN116199605A - Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide - Google Patents

Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide Download PDF

Info

Publication number
CN116199605A
CN116199605A CN202310173559.3A CN202310173559A CN116199605A CN 116199605 A CN116199605 A CN 116199605A CN 202310173559 A CN202310173559 A CN 202310173559A CN 116199605 A CN116199605 A CN 116199605A
Authority
CN
China
Prior art keywords
reaction
chloro
hydroxy
dimethylbenzenesulfonamide
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310173559.3A
Other languages
Chinese (zh)
Inventor
王西
姬猛
任启宣
赵茜阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Ruiteng Pharmaceutical Technology Co ltd
Original Assignee
Shanghai Ruiteng Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ruiteng Pharmaceutical Technology Co ltd filed Critical Shanghai Ruiteng Pharmaceutical Technology Co ltd
Priority to CN202310173559.3A priority Critical patent/CN116199605A/en
Publication of CN116199605A publication Critical patent/CN116199605A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/08Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide, which takes p-chloroanisole as a starting material and comprises the following steps of: chlorosulfonic acid is used as a reaction reagent, and the sulfonylation reaction is carried out in an aprotic solvent 1 or in a solvent-free state; step II, sulfonamide reaction: dimethylamine is used as a reaction reagent, and the sulfonamide reaction is carried out in the presence of alkali and a reaction solvent; step III, demethylation reaction: the demethylation reaction is carried out in aprotic solvent 2 using lewis acid as a reactant. The method has the advantages that the selected initial raw material p-anisole is supplied in a large quantity in the market, the method is low in cost and easy to obtain, the reaction condition is mild, the operation is simple and safe, the post-treatment process is simple and convenient, the crude product is easy to purify without complex modes such as column chromatography, the average yield is more than 80%, the purity is more than 99.0%, and the method is low in cost and suitable for large-scale industrial production.

Description

Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide.
Background
5-chloro-2-hydroxy-dimethylbenzenesulfonamide having the structural formula
Figure BDA0004100024870000011
As an important pharmaceutical and chemical raw material, widely used for synthesis of pharmaceutical intermediates, such documents report more, for example, patent document WO2010/000031 reports that it can be used for synthesis of aids drugs, and US2002006946A1 reports that it can be used for synthesis of drugs for treating thyroid diseases. Whereas few reports have been made regarding the synthesis of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide, the synthesis method is reported in Tetrahedron Letters,2001, vol.42, #49, p.8729-8731, and the specific synthetic route is as follows:
Figure BDA0004100024870000012
however, the existing literature synthesis method has more severe reaction process conditions, the reaction parameters are reported to be required to obtain target compounds in the presence of aluminum trichloride at a temperature of more than 140 ℃, the yield is less than 70%, the industrialization prospect of the route is poor, the equipment requirement is high, and the pollution and the energy consumption are high.
Disclosure of Invention
The invention aims to provide a synthesis method of 5-chloro-2-hydroxy-dimethyl benzene sulfonamide, which adopts p-anisole as a raw material, is low in cost and easy to obtain, has a simple process, is simple and convenient to post-treat and operate, has mild conditions, low reaction cost, high yield and good purity, and is suitable for industrial production.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
the invention provides a synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide, which comprises the following synthesis routes:
Figure BDA0004100024870000021
the method takes p-chloroanisole as a starting material and comprises the following three synthesis steps: i is a sulfonylation reaction; II is amidation reaction; III is a demethylation reaction; specifically comprising:
in the step I, the sulfonylation reaction is carried out in an aprotic solvent 1 or in a solvent-free state by taking chlorosulfonic acid as a reaction reagent;
in the step II, sulfonamide reaction, dimethylamine is used as a reaction reagent, and sulfonamide reaction is carried out in the presence of alkali and a reaction solvent;
in the step III, the demethylation reaction is carried out in an aprotic solvent 2 by taking Lewis acid as a reaction reagent.
Preferably, in step I, the aprotic solvent 1 is selected from one of dichloromethane, toluene, and dichloroethane.
Preferably, in step I, the feed temperature is from-5 to 25℃and preferably from 0 to 10 ℃.
Preferably, in step II, the dimethylamine is selected from one form of dimethylamine hydrochloride, dimethylamine aqueous solution, dimethylamine alcohol solution or dimethylamine tetrahydrofuran solution.
Preferably, in step II, the reaction solvent is selected from one of dichloromethane, toluene, tetrahydrofuran, and water.
Preferably, in step II, the feed temperature is from-5 to 25℃and preferably from 0 to 10 ℃.
Preferably, in step III, the lewis acid is selected from one of aluminum trichloride, boron tribromide, hydrobromic acid.
Preferably, in step III, the aprotic solvent 2 is selected from one of dichloromethane, toluene, tetrahydrofuran, and acetic acid.
Preferably, in step III, the feed temperature is from-5 to 25℃and preferably from 0 to 10 ℃.
Compared with the prior art, the invention has the beneficial effects that: the synthetic route has the advantages of mass supply of the initial raw material p-chloroanisole in the market, low cost, easy acquisition, mild reaction conditions, simple and safe operation, simple post-treatment process, easy purification of crude products, no need of complex modes such as column chromatography and the like, average yield of over 80 percent, purity of over 99.0 percent, low cost and suitability for large-scale industrial production.
Drawings
FIG. 1 is the target product of example 1 1 H-NMR chart.
FIG. 2 is an HPLC chart of the target product in example 1.
FIG. 3 is the target product of example 2 1 H-NMR chart.
FIG. 4 is an HPLC chart of the target product in example 2.
Detailed Description
The invention is further illustrated below in connection with specific examples which are provided solely for the purpose of illustration and are not intended to limit the scope of the invention.
The experimental procedure, in which specific conditions are not noted in the examples below, is generally followed by conventional conditions.
Comparative example 1
The object is prepared in this comparative example reference Tetrahedron Letters,2001, vol.42, #49, p.8729-8731
Figure BDA0004100024870000031
The technical route is as follows: />
Figure BDA0004100024870000032
The method comprises the following steps:
at room temperature (20-30 ℃), add 4-chlorophenyl dimethylsulfamate (CAS number 1135-05-3, 10g,1.0 eq) to 250mL three-necked flask, add aluminum trichloride (10 g,1.0 eq), heat up to 140-145 ℃ in oil bath, keep the temperature for 2 hours, control the raw materials to disappear in TLC, slowly drop the reaction liquid to 100mL diluted hydrochloric acid for quenching, control the temperature to 10-20 ℃, stir for 30 minutes, extract with dichloromethane, dry, concentrate to obtain 7g of yellow solid, recrystallize the solid with about 300mL (PE: EA=2:1) mixed solvent to obtain 5.7g pale yellow solid with purity of 95.7%, yield: 57%.
The following examples were carried out to prepare the target by the synthesis method of the present invention
Figure BDA0004100024870000033
The technical route is as follows:
Figure BDA0004100024870000034
example 1
Step I: chlorosulfonic acid (100 mL, 2.5V/W), N, was added to a 250mL three-necked flask at room temperature (20-30 ℃ C.), and the mixture was stirred at room temperature 2 3, replacing three times, controlling the temperature of an ice salt bath to be 0-5 ℃, slowly dropwise adding p-chloroanisole (40 g), naturally heating to room temperature after adding, reacting for 2 hours, controlling the raw materials to disappear in TLC, slowly dropwise adding the reaction liquid into 200mL of ice water, controlling the temperature to be 10-20 ℃, stirring for 30 minutes, filtering to obtain 73.5g of white solid, baking the material in a 50 ℃ oven for 16 hours to obtain 63g of white solid with the purity of 97.2 percent, and obtaining the yield: 93.3 percent, 1 H-NMR(DMSO):δ(ppm)7.63(d,7H),7.34(dd,1H),6.99(d,1H),3.74(s,3H)。
step II: THF (200 mL, 5V/W) is added into a 500mL three-necked flask at room temperature (20-30 ℃), the sulfonyl chloride compound (40 g,1.0 eq) is stirred and dissolved, and the temperature of the ice salt bath is controlled to be 0+/-5 ℃; t-in = 0 ℃, slowly dropwise adding dimethylamine aqueous solution (77.3 g,2.5 eq), and controlling the temperature to react at 0±5 ℃; incubation for 2 hours, TLC control: ending the reaction; the reaction solution is concentrated under reduced pressure to remove most THF, the rest reaction solution is slowly added into 400g of ice water in a dropwise manner, stirred for 30 minutes, filtered to obtain white solid, and baked for 16 hours at 50 ℃ in an oven to obtain 39.6g of white solid with the purity of 100 percent and the yield: 95.7 percent, 1 H-NMR(DMSO):δ(ppm)7.78-7.63(m,2H),7.30(d,1H),3.90(s,3H),2.74(s,6H)。
step III: DCM (300 mL, 10V/W) is added into a 500mL three-necked flask at room temperature (20-30 ℃), the sulfonamide (30 g,1.0 eq) is stirred and dissolved, and dry ice acetone is cooled to an internal temperature of 0-10 ℃; BBr is slowly dripped by controlling the internal temperature to be between 0 and 10 DEG C 3 (75.3 g,2.5 eq) and slowly returned to room temperature for 2 hours after the end of the dropwise addition; TLC control of reaction junctionsBundling, namely, cooling the reaction liquid to an internal temperature of less than 5 ℃, slowly dropwise adding the reaction liquid into 150mL of ice methanol, and controlling the internal temperature to be less than or equal to 20 ℃; stirring for 30 minutes after the dripping is finished, concentrating under reduced pressure to remove DCM, steaming twice with methanol, pouring a small amount of solvent into 200mL of ice water, stirring for 30 minutes, filtering, and drying to obtain 36.2g of off-white solid; recrystallisation of the solid with about 600mL (PE: ea=2:1) of mixed solvent gives 26.4g of a white solid, purity: 99.6%, yield: 93.4 percent, 1 H-NMR(DMSO):δ(ppm)11.00(s,1H),7.62(d,1H),7.53(dd,1H),7.07(d,1H),2.78(s,6H)。
example 2
Step I: chlorosulfonic acid (12.5L, 2.5V/W) and N are added into a 20L glass reaction kettle at room temperature (20-30 ℃), and then 2 Replacing three times, controlling the temperature of an ice salt bath to be 0-5 ℃, slowly dropwise adding p-chloroanisole (5.0 kg), naturally heating to room temperature for reaction for 2 hours after adding, enabling TLC central control raw materials to disappear, slowly dropwise adding the reaction liquid into 50L ice water, controlling the temperature to be 10-20 ℃, stirring for 30 minutes, filtering to obtain 8.3kg of white solid, and drying the material in a 50 ℃ oven for 16 hours to obtain 7.88kg of white solid with the purity of 91.3 percent and yield: 93.3 percent, 1 H-NMR(DMSO):δ(ppm)7.63(d,7H),7.34(dd,1H),6.99(d,1H),3.74(s,3H)。
step II: THF (39.4L, 5V/W) is added into a 50L reaction kettle at room temperature (20-30 ℃), the sulfonyl chloride compound (7.88 kg,1.0 eq) is stirred and dissolved, and the temperature is controlled to be 0+/-5 ℃; t-in = 0 ℃, slowly dropwise adding dimethylamine aqueous solution (9.2 kg,2.5 eq), and controlling the temperature to react at 0±5 ℃; incubation for 2 hours, TLC control: ending the reaction; the reaction solution is concentrated under reduced pressure to remove most THF, the rest reaction solution is slowly added into 63kg ice water in a dropwise manner, stirred for 30 minutes, filtered to obtain white solid, and baked for 16 hours at 50 ℃ in an oven to obtain 7.8kg white solid with purity: 86.3%, yield: 95.7 percent, 1 H-NMR(DMSO):δ(ppm)7.78-7.63(m,2H),7.30(d,1H),3.90(s,3H),2.74(s,6H)。
step III: under the room temperature condition (20-30 ℃), DCM (70L, 10V/W) is added into a 100L reaction kettle, the sulfonamide (7.8 kg,1.0 eq) is stirred and dissolved, and the temperature is reduced to 0-10 ℃ at the inner temperature; BBr is slowly dripped by controlling the internal temperature to be between 0 and 10 DEG C 3 (19.57 kg,2.5 eq) and slowly returned to room temperature after the end of the dropwise additionReacting for 2 hours; after TLC central control reaction is finished, the reaction liquid is cooled to the internal temperature of less than 5 ℃, and is slowly dripped into 39L of ice methanol, and the internal temperature is controlled to be less than or equal to 20 ℃; stirring for 30 min after the dripping, concentrating under reduced pressure to remove DCM, steaming twice with methanol, adding a small amount of solvent, stirring for 30 min in 54.6L ice water, filtering, and oven drying to obtain white solid; the solid was recrystallized from about 156L (PE: ea=2:1) of mixed solvent to give 6.88kg of white solid with purity: 99.6%, yield: 93.47 percent, 1 H-NMR(DMSO):δ(ppm)8.82(s,1H),7.50(d,1H),7.43(dd,1H),7.02(d,1H),2.79(s,6H)。
table 1: yield of different synthetic processes
Project Feeding amount Yield is good Color of the product
Comparative example 1 10g 57.0% Yellowish light yellow
Example 1 40g 82.1% White-like color
Example 2 5.0kg 83.2% White color
As can be seen from Table 1, the three-step average yield of the products obtained by the synthesis of examples 1-2 is about 80%, which is higher than that of comparative example 1 in the prior art, and the purification process is simple, the production and amplification process is stable, and the color quality of the obtained target product is good.
The previous description of the embodiments is provided to facilitate a person of ordinary skill in the art in order to make and use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles described herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above-described embodiments, and those skilled in the art, based on the principle of the present invention, should make improvements and modifications without departing from the scope of the present invention.

Claims (9)

1. A synthetic method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide comprises the following synthetic route:
Figure FDA0004100024850000011
the method takes p-chloroanisole as a starting material and comprises the following steps:
step I, sulfonylation reaction: chlorosulfonic acid is used as a reaction reagent, and the sulfonylation reaction is carried out in an aprotic solvent 1 or in a solvent-free state;
step II, sulfonamide reaction: dimethylamine is used as a reaction reagent, and the sulfonamide reaction is carried out in the presence of alkali and a reaction solvent;
step III, demethylation reaction: the demethylation reaction is carried out in aprotic solvent 2 using lewis acid as a reactant.
2. The method for synthesizing 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step I, the aprotic solvent 1 is selected from one of dichloromethane, toluene, and dichloroethane.
3. The process for the synthesis of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step I the feed temperature is from-5 to 25 ℃.
4. The method for synthesizing 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step II, the dimethylamine is selected from one form of dimethylamine hydrochloride, dimethylamine aqueous solution, dimethylamine alcohol solution, and dimethylamine tetrahydrofuran solution.
5. The method for synthesizing 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step II, the reaction solvent is selected from one of dichloromethane, toluene, tetrahydrofuran, and water.
6. The process for the synthesis of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step II the feed temperature is from-5 to 25 ℃.
7. The method for synthesizing 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step III, the lewis acid is selected from one of aluminum trichloride, boron tribromide, hydrobromic acid.
8. The method for synthesizing 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step III, the aprotic solvent 2 is selected from one of dichloromethane, toluene, tetrahydrofuran, and acetic acid.
9. The process for the synthesis of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide according to claim 1, wherein in step III, the addition temperature is from-5 to 25 ℃.
CN202310173559.3A 2023-02-27 2023-02-27 Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide Pending CN116199605A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310173559.3A CN116199605A (en) 2023-02-27 2023-02-27 Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310173559.3A CN116199605A (en) 2023-02-27 2023-02-27 Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide

Publications (1)

Publication Number Publication Date
CN116199605A true CN116199605A (en) 2023-06-02

Family

ID=86514439

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310173559.3A Pending CN116199605A (en) 2023-02-27 2023-02-27 Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide

Country Status (1)

Country Link
CN (1) CN116199605A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1221401A (en) * 1996-04-09 1999-06-30 Nps医药公司 Calcilytic compounds
CN101443003A (en) * 2006-05-18 2009-05-27 默克专利有限公司 Triazole derivatives II
WO2010000031A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Imidazopyrimidinones and uses thereof
WO2021007663A1 (en) * 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2022032144A1 (en) * 2020-08-07 2022-02-10 The Broad Institute, Inc. Substrate adaptor inhibitors of prmt5 and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1221401A (en) * 1996-04-09 1999-06-30 Nps医药公司 Calcilytic compounds
CN101443003A (en) * 2006-05-18 2009-05-27 默克专利有限公司 Triazole derivatives II
WO2010000031A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Imidazopyrimidinones and uses thereof
WO2021007663A1 (en) * 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2022032144A1 (en) * 2020-08-07 2022-02-10 The Broad Institute, Inc. Substrate adaptor inhibitors of prmt5 and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
G. ANTHONY BENSON等: ""A new synthetic route to aryl hydroxysulfonamides via a novel Fries-type rearrangement of aryl N, N-dialkylsulfamates"", TETRAHEDRON LETTERS, vol. 42, pages 8729 - 8731, XP004321535, DOI: 10.1016/S0040-4039(01)01893-7 *

Similar Documents

Publication Publication Date Title
CN110028462B (en) Method for preparing isoxazoline intermediate and isoxazoline
CA3022388C (en) Method for preparing azoxystrobin intermediates
CN108947884A (en) A kind of Preparation Method And Their Intermediate of imrecoxib
CN114085234A (en) Process for preparing 1, 3-benzodioxole heterocycles
CN111533677A (en) Method for synthesizing arbidol hydrochloride intermediate
CN110790721B (en) Synthetic method of ceftazidime side chain ethyl ester
CN114315823B (en) Intermediate of berberine hydrochloride and analogues thereof and preparation method thereof
CN101735029B (en) Synthesis method of hellebore aldehyde
US10807979B2 (en) 4,5-disubstituted-1H-pyrrolo(2,3-f)quinolin-2,7,9-tricarboxylate compound and use thereof
CN116199605A (en) Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide
CN108164423B (en) Preparation method of naftifine hydrochloride
CN109721552B (en) Preparation method of gefitinib
CN101219967B (en) Process for producing 2-nitryl substituted benzene ethane nitrile compounds
CN104311469B (en) A kind of synthetic method of substituted indole-3-acetic acid
CN102382053B (en) A kind of method preparing tolvaptan intermediate
JP6260385B2 (en) Method for producing 2-hydroxymethyl-2,3-dihydro-thieno [3,4-b] [1,4] dioxin-5,7-dicarboxylic acid dialkyl ester
CN112679440A (en) Preparation method of 5-n-butyl-2-ethylamino-4-hydroxy-6-methylpyrimidine
WO2011060624A1 (en) Process for preparing 2-methyl-4-amino-5-cyanopyrimidine
CN112250586A (en) Preparation method of terbutaline sulfate and B crystal form thereof
CN109721551B (en) Preparation method of 3, 4-dihydro-7-methoxy-4-oxoquinazolin-6-ol acetate
CN110835308A (en) Preparation method of halogenated o-aminobenzoic acid
US11459291B2 (en) Method of preparation of (1R,3S)-3-amino-1-cyclopentanol and salt thereof
CN110818679B (en) Synthetic method of 4-bromobenzo [ b ] thiophene
CN115894518B (en) Synthesis method of pinoxaden metabolite M3
CN108299169B (en) Synthesis method of 6-chloro-3, 4-dihydro-2H-1-naphthalenone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination